MX2 wards off HIV-1 and herpes simplex virus-1 by assembling structures in the cell that lure and then trap them or even take ...

A group of researchers led by Xavier Saelens and Sven Eyckerman at the VIB-UGent Center for Medical Biotechnology discovered ...

The key outcome of the HIV Host Genome Project is to understand protective mechanisms in a population that’s infected with the virus with the highest burden of disease. Previously, most research has ...

A group of researchers led by Xavier Saelens and Sven Eyckerman at the VIB-UGent Center for Medical Biotechnology discovered how a protein linked to the human immune system wards off HIV-1 and herpes ...

Gilead Sciences and Merck presented Phase 2 results showing 94.2% viral suppression in HIV patients treated with islatravir and lenacapavir. Both weekly and daily treatments achieved comparable ...

However, Ndung'u explained that the mechanisms that subdue the virus in this rare group are ... of research initiatives like the HIV Host Genome project, which aims to identify any distinct ...

A study discovered how the MX protein traps HIV-1 and herpes viruses by assembling decoy structures that mimic nuclear pore ...

Soft Condensed Matter and Biophysics, Department of Physics and Debye Institute, Utrecht University, Utrecht, The Netherlands ...

Many HIV-serodiscordant couples desire children and physician-assisted techniques can help individuals achieve pregnancy while reducing the risk of seroconversion in their seronegative partner.

It is just as safe and effective for people with HIV in need of kidney transplantation to get their organ from donors who are also HIV positive as it is from donors who are not infected with the virus ...

Human immunodeficiency virus or HIV damages the immune system to prevent the body from fighting off disease and infection. If left untreated, HIV can lead to acquired immunodeficiency syndrome (AIDS) ...

[JOHANNESBURG] A rare group of HIV-positive people who maintain undetectable levels of the virus in their blood without medication could hold the key to new therapies for others living with the ...